Table 3.
Heart failure stage | AHA/ACC description |
---|---|
Stage A | Patients without identified structural or functional cardiac abnormality or ventricular function abnormality but at high risk of developing HF because of the presence of a condition strongly associated with the development of HF. Examples: anthracycline exposure, known pathogenic sarcomeric gene mutation including dystrophinopathies. |
Stage B | Patients with structural heart disease or ventricular function abnormality that is strongly associated with the development of HF but without HF signs or symptoms, past or present. Examples: asymptomatic patient with CHD status post-surgical correction with residual lesion, isolated left ventricle non-compaction. |
Stage C | Patients with current or prior symptoms of HF associated with underlying structural heart disease, or ventricular function abnormality. Examples: acute myocarditis., dilated cardiomyopathy, mitral or aortic regurgitation. |
Stage D | Patients with advanced structural heart disease and refractory symptoms of HF requiring specialized interventions. Example: Inotropic dependency patient in end stage of dilated cardiomyopathy. |